"Executive Summary Pharmacogenetics Testing in Psychiatry/Depression Market Size and Share Across Top Segments CAGR Value The global pharmacogenetics testing in psychiatry/depression market size was valued at USD 1.34 billion in 2024 and is expected to reach USD 2.97 billion by 2032, at a CAGR of 10.4% during the forecast period To better structure this...